Literature DB >> 16921878

Nested polymerase chain reaction detection and duration of porcine circovirus type 2 in semen with sperm morphological analysis from naturally infected boars.

Kathleen A McIntosh1, John C S Harding, Sarah Parker, John A Ellis, Greg D Appleyard.   

Abstract

A nested polymerase chain reaction (nPCR) protocol was applied to porcine semen to demonstrate the porcine circovirus type 2 (PCV2) shedding patterns and duration in naturally infected boars. Sperm morphology analysis was performed on a subset of samples to determine if the presence of PCV2 DNA in semen was associated with reduced semen quality. Semen was collected serially from 43 boars representing 6 breeds, aged 33.9 to 149.3 weeks. Of the 903 semen samples collected, 30 samples (3.3%) were positive for PCV2 DNA by nPCR from 13 boars. Boars shedding PCV2 DNA in semen ranged between 35.9 and 71.0 weeks of age, and shedding occurred during a period of up to 27.3 weeks. A semen nPCR test was 2.6 times more likely to be positive when collected from pigs that were < or =52 weeks of age, and 3.0 times more likely to be positive when collected from pigs that were < or =26 weeks from time of entry into the stud main unit (generalized estimating equations: P = 0.02; 95% confidence interval [CI] of the odds ratio 1.2 to 5.5, and P = 0.01; 95% CI of the odds ratio 1.3 to 6.9, respectively). These results demonstrate a sporadic and long-term shedding pattern of PCV2 DNA in semen from naturally infected boars. PCV2 DNA in semen does not appear to have detrimental effects on sperm morphology; however, boar age and, possibly, breed may contribute to the persistence of PCV2-shedding in semen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16921878     DOI: 10.1177/104063870601800410

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinically infected with porcine circovirus type 2.

Authors:  J Kurmann; T Sydler; E Brugnera; E Buergi; M Haessig; M Suter; X Sidler
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

2.  Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero.

Authors:  D M Madson; A R Patterson; S Ramamoorthy; N Pal; X J Meng; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

3.  Insights into the evolutionary history of an emerging livestock pathogen: porcine circovirus 2.

Authors:  Cadhla Firth; Michael A Charleston; Siobain Duffy; Beth Shapiro; Edward C Holmes
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

4.  Quantitative polymerase chain reaction for Porcine circovirus-2 in swine feces in a Porcine circovirus disease-affected commercial herd and a nonaffected commercial herd.

Authors:  Kathleen A McIntosh; John C S Harding; Sarah Parker; Steven Krakowka; Gordon Allan; John A Ellis
Journal:  Can Vet J       Date:  2008-12       Impact factor: 1.008

5.  Reproduction in porcine circovirus type 2 (PCV2) seropositive gilts inseminated with PCV2b spiked semen.

Authors:  Giuseppe Sarli; Federico Morandi; Serena Panarese; Barbara Bacci; Domenico Ferrara; Carlo Bianco; Laura Fusaro; Maria Laura Bacci; Giovanna Galeati; Michele Dottori; Paolo Bonilauri; Davide Lelli; Giorgio Leotti; Thais Vila; Francois Joisel; Gordon Allan; Cinzia Benazzi; Fabio Ostanello
Journal:  Acta Vet Scand       Date:  2012-08-31       Impact factor: 1.695

6.  Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars.

Authors:  Darin M Madson; Sheela Ramamoorthy; Chris Kuster; Narinder Pal; Xiang-Jin Meng; Patrick G Halbur; Tanja Opriessnig
Journal:  Vet Res       Date:  2008-10-31       Impact factor: 3.683

Review 7.  Porcine circovirus type 2 and porcine circovirus-associated disease.

Authors:  J Gillespie; T Opriessnig; X J Meng; K Pelzer; V Buechner-Maxwell
Journal:  J Vet Intern Med       Date:  2009-09-22       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.